Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study

S. Bak, I. Tsiropoulos, J. Kjærsgaard, M. Andersen, E. Mellerup, J. Hallas, L. G. García Rodríguez, K. Christensen, D. Gaist
{"title":"Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study","authors":"S. Bak, I. Tsiropoulos, J. Kjærsgaard, M. Andersen, E. Mellerup, J. Hallas, L. G. García Rodríguez, K. Christensen, D. Gaist","doi":"10.1161/01.STR.0000018589.56991.BA","DOIUrl":null,"url":null,"abstract":"Background and Purpose— Selective serotonin reuptake inhibitors (SSRIs) have been associated with increased risk of bleeding complications, possibly as a result of inhibition of platelet aggregation. Little is known about the risk of intracerebral hemorrhage in users of SSRIs and whether the effect on platelet aggregation reduces the risk of ischemic stroke. We used population-based data to estimate the risk of hemorrhagic and ischemic stroke in users of SSRIs. Methods— We performed a nested case-control study in Funen County (465 000 inhabitants), Denmark. All patients with a first-ever stroke discharge diagnosis in the period of 1994 to 1999 were identified, and a validated diagnosis of stroke was reached in 4765 cases. In all, 40 000 controls were randomly selected from the background population. Information on drug use for cases and controls was retrieved from a prescription registry with full coverage of the county. Odds ratios were adjusted for age, sex, calendar year, and use of other medication. To evaluate the effect of various potential confounders not recorded in the register data, we performed separate analyses on data from 2 large population-based surveys with more detailed information on risk factors. Results— Of 659 patients with hemorrhagic stroke, 21 were current users of SSRIs. The adjusted odds ratio of hemorrhagic stroke in current SSRI users compared with never users was 1.0 [95% confidence interval (CI), 0.6 to 1.6]. Of 2717 patients with ischemic stroke, 100 were current users of SSRIs, and the adjusted odds ratio of ischemic stroke in cases compared with controls was 1.1 (95% CI, 0.9 to 1.4). The survey data indicated that additional confounder control would not have led to an increase in the relative risk estimates. Conclusions— Current exposure to SSRIs is not associated with increased risk of intracerebral hemorrhage and is probably not associated with a decreased risk of ischemic stroke.","PeriodicalId":22274,"journal":{"name":"Stroke: Journal of the American Heart Association","volume":"33 1","pages":"1465-1473"},"PeriodicalIF":0.0000,"publicationDate":"2002-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"139","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke: Journal of the American Heart Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/01.STR.0000018589.56991.BA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 139

Abstract

Background and Purpose— Selective serotonin reuptake inhibitors (SSRIs) have been associated with increased risk of bleeding complications, possibly as a result of inhibition of platelet aggregation. Little is known about the risk of intracerebral hemorrhage in users of SSRIs and whether the effect on platelet aggregation reduces the risk of ischemic stroke. We used population-based data to estimate the risk of hemorrhagic and ischemic stroke in users of SSRIs. Methods— We performed a nested case-control study in Funen County (465 000 inhabitants), Denmark. All patients with a first-ever stroke discharge diagnosis in the period of 1994 to 1999 were identified, and a validated diagnosis of stroke was reached in 4765 cases. In all, 40 000 controls were randomly selected from the background population. Information on drug use for cases and controls was retrieved from a prescription registry with full coverage of the county. Odds ratios were adjusted for age, sex, calendar year, and use of other medication. To evaluate the effect of various potential confounders not recorded in the register data, we performed separate analyses on data from 2 large population-based surveys with more detailed information on risk factors. Results— Of 659 patients with hemorrhagic stroke, 21 were current users of SSRIs. The adjusted odds ratio of hemorrhagic stroke in current SSRI users compared with never users was 1.0 [95% confidence interval (CI), 0.6 to 1.6]. Of 2717 patients with ischemic stroke, 100 were current users of SSRIs, and the adjusted odds ratio of ischemic stroke in cases compared with controls was 1.1 (95% CI, 0.9 to 1.4). The survey data indicated that additional confounder control would not have led to an increase in the relative risk estimates. Conclusions— Current exposure to SSRIs is not associated with increased risk of intracerebral hemorrhage and is probably not associated with a decreased risk of ischemic stroke.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
选择性血清素再摄取抑制剂与卒中风险:一项基于人群的病例对照研究
背景和目的:选择性血清素再摄取抑制剂(SSRIs)与出血并发症的风险增加有关,可能是抑制血小板聚集的结果。对于SSRIs使用者脑出血的风险以及对血小板聚集的影响是否降低缺血性卒中的风险知之甚少。我们使用基于人群的数据来估计SSRIs使用者出血性和缺血性中风的风险。方法:我们在丹麦Funen县(46.5万居民)进行了巢式病例对照研究。所有1994 ~ 1999年首次卒中出院诊断的患者均被确定,4765例卒中确诊。总共从背景人群中随机选择了4万名对照。病例和对照的药物使用信息是从覆盖全县的处方登记处检索的。比值比根据年龄、性别、日历年和使用其他药物进行调整。为了评估登记数据中未记录的各种潜在混杂因素的影响,我们对来自2个大型人群调查的数据进行了单独分析,这些调查提供了更详细的风险因素信息。结果- 659例出血性卒中患者中,21例目前使用SSRIs。目前服用SSRI的患者与从未服用SSRI的患者相比,出血性卒中的校正优势比为1.0[95%可信区间(CI), 0.6 ~ 1.6]。在2717例缺血性卒中患者中,有100例目前使用SSRIs,与对照组相比,缺血性卒中的校正优势比为1.1 (95% CI, 0.9 ~ 1.4)。调查数据表明,额外的混杂因素控制不会导致相对风险估计的增加。结论:当前暴露于SSRIs与脑出血风险增加无关,也可能与缺血性卒中风险降低无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Recurrent Stroke in Patients With Symptomatic Carotid Artery Occlusion Is Associated With High-Volume Flow to the Brain and Increased Collateral Circulation Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs: A Nested Case-Control Study Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke: Present Status Risk Factors for Falling in Home-Dwelling Older Women With Stroke: The Women’s Health and Aging Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1